These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors. Ficociello LH, Perkins BA, Silva KH, Finkelstein DM, Ignatowska-Switalska H, Gaciong Z, Cupples LA, Aschengrau A, Warram JH, Krolewski AS. Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452 [Abstract] [Full Text] [Related]
8. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study. Soedamah-Muthu SS, Visseren FL, Algra A, van der Graaf Y, SMART Study Group. Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132 [Abstract] [Full Text] [Related]
9. Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes from 1990 to 2006. Cho YH, Craig ME, Hing S, Gallego PH, Poon M, Chan A, Donaghue KC. Pediatr Diabetes; 2011 Dec; 12(8):682-9. PubMed ID: 21435138 [Abstract] [Full Text] [Related]
10. Natural course of untreated microalbuminuria in children and adolescents with type 1 diabetes and the importance of diabetes duration and immigrant status: longitudinal analysis from the prospective nationwide German and Austrian diabetes survey DPV. Galler A, Haberland H, Näke A, Hofer S, Holder M, Raile K, Holl RW, German Federal Ministry for Education and Research BMBF Competence Network of Diabetes Mellitus. Eur J Endocrinol; 2012 Mar; 166(3):493-501. PubMed ID: 22199141 [Abstract] [Full Text] [Related]
13. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease. Bleyer AJ, Sedor JR, Freedman BI, O'Brien A, Russell GB, Graley J, Schelling JR. Am J Kidney Dis; 2008 Jan; 51(1):29-37. PubMed ID: 18155530 [Abstract] [Full Text] [Related]
14. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, Appleyard M, Jensen JS. Circulation; 2004 Jul 06; 110(1):32-5. PubMed ID: 15210602 [Abstract] [Full Text] [Related]
15. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving HH. BMJ; 2004 May 08; 328(7448):1105. PubMed ID: 15096438 [Abstract] [Full Text] [Related]
16. [Prevalence and determinants of microalbuminuria and macroalbuminuria in children and young adults with type 1 diabetes in Kinshasa]. Rissassi JR, Nseka M, Jadoul M, Lepira FB, Mvitu M, Mbenza G, Yekoladio D, Aloni M, Nge OO. Nephrol Ther; 2010 Feb 08; 6(1):40-6. PubMed ID: 19853548 [Abstract] [Full Text] [Related]
17. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus. Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H. J Diabetes Complications; 2008 Feb 08; 22(6):384-8. PubMed ID: 18413152 [Abstract] [Full Text] [Related]
20. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study. Costacou T, Ellis D, Fried L, Orchard TJ. Am J Kidney Dis; 2007 Nov 08; 50(5):721-32. PubMed ID: 17954285 [Abstract] [Full Text] [Related] Page: [Next] [New Search]